Strona 4 - Najlepsi onkolodzy – TOP 652 lekarzy

Profesor dr Sefik Igdem specjalizuje się w onkologii radiacyjnej, wykorzystując zaawansowane technologie Truebeam Stx i Halcyons do precyzyjnego leczenia nowotworów głowy i szyi w szpitalu Gayrettepe Florence Nightingale.

• Ponad 25 lat doświadczenia w onkologii radiacyjnej
• Ekspert w leczeniu konformalnym dla precyzyjnego celowania w guz
• Profesor na Uniwersytecie T.R. Demiroğlu Bilim – kształci przyszłych onkologów
• Specjalizuje się w minimalizowaniu skutków ubocznych dzięki zaawansowanym technikom napromieniania

Dr Yahya Ozel kształcił się w elitarnej Klinice Chirurgii Wątroby, Dróg Żółciowych i Trzustki Uniwersytetu Tokijskiego, wprowadzając japońską precyzję do złożonych przypadków onkologicznych.

• Ponad 30 lat doświadczenia chirurgicznego ze szczególnym uwzględnieniem technik małoinwazyjnych
• Certyfikowany w zakresie endoskopii chirurgicznej i zaawansowanych procedur robotycznych
• Członek kadry akademickiej na Uniwersytecie Doğuş, kształcący przyszłych chirurgów
• Specjalizuje się w chirurgii nowotworów dróg żółciowych, trzustki i jelita grubego

Ponad 500 wykonanych prostatektomii robotycznych – dr Alcaraz specjalizuje się w małoinwazyjnej onkologii urologicznej z wykorzystaniem systemu Da Vinci w Teknon Medical Center.

• Ponad 30 lat doświadczenia jako uroonkolog i transplantolog
• Kierownik Oddziału Urologii i Transplantacji Nerek
• Ekspert w tradycyjnych i robotycznych metodach chirurgicznych
• Członek Europejskiego Towarzystwa Urologicznego i Amerykańskiej Konfederacji Urologicznej

Docent Emine Yildirim specjalizuje się w chirurgii oszczędzającej pierś oraz potrójnie ujemnym raku piersi w Szpitalu Uniwersyteckim Atlas.

• Ponad 20 lat doświadczenia w chirurgii onkologicznej
• Certyfikowana w zakresie zaawansowanych technik, takich jak rekonstrukcja wolnym płatem
• Badaczka z publikacjami na temat wyników chemioterapii neoadjuwantowej
• Aktywna uczestniczka międzynarodowych konferencji dotyczących raka piersi

Prof. Zvi Cohen is Director of the Neurosurgery Department and the Neuro-Oncology Unit at Sheba Medical Center. He is a neurosurgeon and neuro-oncology expert. He was included in Forbes Israel’s Best Doctors 2025. He leads clinical research on drug therapies for malignant brain tumors. He also founded Sheba’s brain tumor tissue bank.

He is board-certified in neurosurgery. He trained at Tel Aviv University. He completed fellowships in neuroradiology at Beth Israel and in neurosurgical oncology at MD Anderson. His practice covers complex brain, pituitary, spine, and spinal cord tumors. He has expertise in stereotactic biopsies, image-guided resections, intraoperative MRI, navigation systems, and radiosurgery. He is a member of the Society for Neuro-Oncology and the Israeli Association of Neurological Surgeons.

Dr. David Kuczer is a specialist in radio-oncology with many years of experience in cancer diagnosis and treatment. He offers fast access to precise radiotherapy based on current scientific standards.

He is a member of the Cancer Center at the Vienna Private Clinic. He presents each patient to the in-house tumor board. This allows an interdisciplinary discussion by an internationally renowned team and helps select the best treatment.

All radiation treatments are provided in close cooperation with Amethyst Radiotherapy at the Vienna Private Clinic.

Dr. Shira Felder is a senior radiation oncologist. She focuses on gynecologic and urologic cancers. She has advanced expertise in VMAT, IMRT, SBRT, and gynecologic brachytherapy. She delivers precise treatment with fewer side effects.

She heads the Gynecologic Oncology Service at Sheba Medical Center. She is a senior physician in the Radiation Oncology Division. She earned her MD at Hadassah. She completed residency at Sheba and a fellowship in the Radiation Medicine Program at the University of Toronto and Princess Margaret Cancer Centre. She is board-certified in Radiation Oncology. She is a member of ESTRO, the Israeli oncology societies, the CPSO, and the CMA.

Her research covers brachytherapy patient safety. It also includes stereotactic ablative radiotherapy for stage I lung cancer. She has studied treatment delays in cervical cancer. She has examined vitamin D deficiency in oncology patients.

Mali interdisciplinary hospital is integrating conventional, regenerative and precision medicine. It divides into 11 departments, there are 35 beds in total, including 12 intensive care beds, 23 general beds, 2 emergency and operating rooms, 1 plastic surgical room, 1 Gastro-colonoscopic room. Focus on round-trip treatment with modern medical technology to reduce the cost of hospitalization and the healing time. It also integrating regenerative medicine to repair the body and precision medicine for preventing and treating chronic non-communicable diseases (NCDs) with better results, we provide these services in a greenery atmosphere. Allowing clients to receive the following benefits.

1. Far away from NCDs & It’s complication

2. Good quality of life

3. Youthful lively life

4. Longevity

Dr. Einat Shacham‑Shmueli is a senior medical oncologist at the Gastrointestinal Clinic, Cancer Center, Sheba Medical Center. She treats cancers of the colon, stomach, and pancreas. She also manages metastatic disease. She uses precision diagnostics and biomarkers, systemic therapies, and radiotherapy. Care is provided within a multidisciplinary team.

She has authored more than 25 peer‑reviewed papers on GI oncology, tumor biology, and new treatments. Her work includes studies on stenting for malignant colonic obstruction. She serves as an investigator in international programs, including the NCI, the Radiation Therapy Oncology Group, and the Cancer Therapy Evaluation Program.

Education: MD, Tel Aviv University. Oncology residency, Tel Aviv Sourasky Medical Center. Advanced training in GI oncology, UCSF. Accreditations: Board certified in Oncology and Gastroenterology. Member, Israel Society of Oncology and Radiotherapy.

Dr. Enrique Grande, MD, PhD, MSc, is a medical oncologist with more than 20 years of experience. He is an international expert in genitourinary and neuroendocrine tumors. He directs the Medical Oncology Department and the One Oncology Madrid Cancer Program at QuirónSalud, Spain’s largest private healthcare network. He leads an integrated, multidisciplinary model with access to targeted therapies and clinical trials.

He is a pioneer in precision oncology. He uses molecular profiling and biomarker-based care. He has authored more than 300 peer-reviewed papers. He serves as a principal investigator and sits on steering committees for many international trials. These studies help set standards of care in urothelial bladder and neuroendocrine tumors. He contributes to guidelines and programs at ESMO, ASCO, ENETS, and EAU.

Professor Dov Zippel is a general surgeon and surgical oncologist. He specializes in breast disease and melanoma. He leads the Meirav Breast Center at Sheba Medical Center. He also serves at the Ella Lemelbaum Institute for Immuno-Oncology. In 2025, Forbes Israel named him to its Best Doctors list.

Expertise: advanced care for benign and malignant breast tumors. Minimally invasive and breast-conserving surgery. Surgical treatment of melanoma and other skin cancers.

Accreditations: MD, Tel Aviv University. Residency in general surgery, Sheba Medical Center. Fellowship in surgical oncology, University of Calgary. Board-certified in general surgery and surgical oncology. Research includes intact breast lesion excision and perioperative BRAF inhibitors for stage III melanoma.

Kierownik Oddziału Radioterapii Onkologicznej w Niemieckim Centrum Onkologii – specjalizuje się w interwencyjnych technikach radioterapii w celu precyzyjnego celowania w nowotwór.

• Stopień doktora uzyskany na Uniwersytecie im. Johanna Wolfganga Goethego
• Ponad 14 lat doświadczenia w radioterapii onkologicznej
• Ekspert w dziedzinie brachyterapii i zaawansowanych metod napromieniania
• Łączy wiedzę kliniczną z przeszkoleniem w zakresie zarządzania opieką zdrowotną

Specjalizuje się w nowoczesnej radioterapii raka prostaty – dr Zamboglou kieruje badaniami na Uniwersytecie we Fryburgu i jest laureatem nagrody Hermana Holthusena.

• Certyfikowany specjalista radioterapii z ponad 10-letnim doświadczeniem
• Zaproszony ekspert do tworzenia zarówno niemieckich, jak i europejskich wytycznych dotyczących raka prostaty
• Zastępca dyrektora medycznego w Niemieckim Instytucie Medycznym (GMI)
• Autor licznych publikacji na temat technik precyzyjnej radioterapii

Specjalizuje się w integracyjnym leczeniu nowotworów w Biological Medicine - Integrative Health Center Baku, łącząc terapię jemiołą i wysokimi dawkami witaminy C z metodami konwencjonalnymi.

• Ekspert w leczeniu hormonalnym raka piersi
• Specjalista w łagodzeniu skutków ubocznych chemioterapii i radioterapii
• Uczestnik międzynarodowych konferencji z lekarzami z Niemiec i Turcji
• Stosuje naturalne metody uśmierzania bólu i przedłużania życia pacjentów onkologicznych

Dr. Almog Ben-Yaacov is an Attending Surgeon in the Department of General and Oncological Surgery (Surgery C) at Sheba Medical Center. He specializes in cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC). His clinical focus includes gastric cancer, sarcoma, and complex colorectal malignancies. Since 2018, he has performed more than 200 HIPEC procedures.

MD, Semmelweis University, 2006, with honors. Training in cardiothoracic surgery at Sheba Medical Center. Residency in general surgery at Montefiore (Albert Einstein) and at Rabin (Beilinson). Board-certified in General Surgery and in Surgical Oncology.

Advanced training includes ESSO-certified HIPEC in Hamburg. Microwave liver ablation in Reims. NanoKnife at King’s College London. Advanced surgical oncology at Memorial Sloan Kettering (2019). His publications cover CRS+HIPEC outcomes and Hartmann’s reversal.

Dr. Yuri Goldes is a general surgeon with more than 20 years of clinical experience. He specializes in upper gastrointestinal and oncologic surgery. He is Deputy Director of the Department of General Surgery and Transplantation at Sheba Medical Center in Tel Aviv. He also leads the Upper GI Surgery Unit. He was named to Forbes Israel’s Best Doctors in 2025. He is ranked among Israel’s Best Gastrointestinal Surgeons by Forbes. In 2019, he received the Israeli Ministry of Health “Best Doctor of the Year” award.

He is an expert in advanced minimally invasive and robotic surgery. He treats diaphragmatic hernia, achalasia, GERD, and gallbladder disease. He also performs oncologic surgery for pancreatic, gastric, and esophageal cancers. He uses laparoscopic and robotic techniques.

He pioneered some of Israel’s first robotic oncologic resections of the stomach and pancreas. He is among a small group worldwide who perform minimally invasive Whipple procedures (pancreaticoduodenectomy) using advanced laparoscopy. He applies methods that improve outcomes and speed recovery. He provides personalized care.

Dr Aydogdu specjalizuje się we wczesnym wykrywaniu nowotworów u dzieci, co jest kluczowym aspektem onkologii dziecięcej.

• Koncentruje się na prezentacjach i dyskusjach dotyczących wykrywania nowotworów u dzieci
• Pracuje w szpitalu Liv Bona Dea w Baku
• Przyczynia się do postępów w onkologii dziecięcej

Nagradzany onkolog dziecięcy specjalizujący się w mięsakach kości i tkanek miękkich w szpitalu dziecięcym SJD Barcelona Children's Hospital – jednej z najlepszych placówek pediatrycznych w Europie.

• Kieruje Oddziałem Hematologii i Onkologii oraz Laboratorium Guzów Rozwojowych
• Opracował bezradiacyjną metodę leczenia glejaków rdzenia kręgowego
• Szkolił się w Memorial Sloan Kettering Cancer Center w zakresie onkologii dziecięcej
• Opublikował ponad 70 prac naukowych na temat nowotworów złośliwych u dzieci
• Laureat wielu międzynarodowych nagród za badania nad nowotworami u dzieci

Prof. Amit Tirosh is a senior endocrinologist and Head of the Neuroendocrine Tumors Service at Sheba Medical Center. He specializes in neuroendocrine tumors (NETs).

His work centers on hereditary NET syndromes. He is affiliated with the NIH in MEN1 research. He serves on an international VHL expert panel and helped write VHL management guidelines. He is the primary contact at Sheba’s multidisciplinary VHL clinic.

He leads the Endocrine Oncology Bioinformatics Lab. He collaborates with international teams, including the Weizmann Institute. He provides advanced NET care, including PRRT.

He earned his MD from the Hebrew University–Hadassah. He completed a residency at Assaf HaRofeh, an endocrinology fellowship at Rabin, and training at the NIH. He is board-certified in Endocrinology. He is a member of the Israeli Society of Endocrinology, the Endocrine Society, and the European Neuroendocrine Tumor Society. He has authored over 40 peer-reviewed papers, including in JAMA, Gastroenterology, and Radiology.